Hofer, Silvia

Rothermundt, Christian; Andreou, Dimosthenis; Blay, Jean-Yves; Brodowicz, Thomas; Desar, Ingrid M E; Dileo, Palma; Gelderblom, Hans; Haas, Rick; Jakob, Jens; Jones, Robin L; Judson, Ian; Kunz, Wolfgang G; Liegl-Atzwanger, Berndadette; Lindner, Lars H; Messiou, Christina; Miah, Aisha B; Reichardt, Peter; Szkandera, Joanna; van der Graaf, Winette T A; van Houdt, Winan J; ... (2023). Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022. European journal of cancer, 180, pp. 158-179. Elsevier 10.1016/j.ejca.2022.11.008

Hofer, Silvia; Keller, Kristina; Imbach, Lukas; Roelcke, Ulrich; Hutter, Gregor; Hundsberger, Thomas; Hertler, Caroline; Le Rhun, Emilie; Vasella, Flavio; Cordier, Dominik; Neidert, Marian; Hottinger, Andreas; Migliorini, Denis; Pflugshaupt, Tobias; Eggenberger, Noemi; Baumert, Brigitta; Läubli, Heinz; Gramatzki, Dorothee; Reinert, Michael; Pesce, Gianfranco; ... (2021). Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM). Swiss medical weekly, 151, w20501. EMH Media 10.4414/smw.2021.20501

Roth, Patrick; Hottinger, Andreas F; Hundsberger, Thomas; Läubli, Heinz; Schucht, Philippe; Reinert, Michael; Mamot, Christoph; Roelcke, Ulrich; Pesce, Gianfranco; Hofer, Silvia; Weller, Michael (2020). A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults. Swiss medical weekly, 150(w20256), w20256. EMH Schweizerischer Ärzteverlag 10.4414/smw.2020.20256

Capper, David; Jones, David T. W.; Sill, Martin; Hovestadt, Volker; Schrimpf, Daniel; Sturm, Dominik; Koelsche, Christian; Sahm, Felix; Chavez, Lukas; Reuss, David E.; Kratz, Annekathrin; Wefers, Annika K.; Huang, Kristin; Pajtler, Kristian W.; Schweizer, Leonille; Stichel, Damian; Olar, Adriana; Engel, Nils W.; Lindenberg, Kerstin; Harter, Patrick N.; ... (2018). DNA methylation-based classification of central nervous system tumours. Nature, 555(7697), pp. 469-474. Macmillan Journals Ltd. 10.1038/nature26000

Gramatzki, Dorothee; Dehler, Silvia; Rushing, Elisabeth Jane; Zaugg, Kathrin; Hofer, Silvia; Yonekawa, Yasuhiro; Bertalanffy, Helmut; Valavanis, Anton; Korol, Dimitri; Rohrmann, Sabine; Pless, Miklos; Oberle, Joachim; Roth, Patrick; Ohgaki, Hiroko; Weller, Michael (2016). Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009. Cancer, 122(14), pp. 2206-2215. John Wiley & Sons 10.1002/cncr.30023

Sturm, Dominik; Orr, Brent A; Toprak, Umut H; Hovestadt, Volker; Jones, David T W; Capper, David; Sill, Martin; Buchhalter, Ivo; Northcott, Paul A; Leis, Irina; Ryzhova, Marina; Koelsche, Christian; Pfaff, Elke; Allen, Sariah J; Balasubramanian, Gnanaprakash; Worst, Barbara C; Pajtler, Kristian W; Brabetz, Sebastian; Johann, Pascal D; Sahm, Felix; ... (2016). New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell, 164(5), pp. 1060-1072. Cell Press 10.1016/j.cell.2016.01.015

Valko, Philipp O; Siddique, Asim; Linsenmeier, Claudia; Zaugg, Kathrin; Held, Ulrike; Hofer, Silvia (2015). Prevalence and predictors of fatigue in glioblastoma: a prospective study. Neuro-Oncology, 17(2), pp. 274-281. Oxford University Press 10.1093/neuonc/nou127

Hofer, Silvia; Elandt, Katarzyna; Greil, Richard; Hottinger, Andreas F; Huber, Urs; Lemke, Dieter; Marosi, Christine; Ochsenbein, Adrian; Pichler, Josef; Roelcke, Ulrich; Weder, Patrik; Zander, Thilo; Wick, Wolfgang; Weller, Michael (2011). Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials. Acta oncologica, 50(5), pp. 630-5. Stockholm: Acta Oncologica 10.3109/0284186X.2011.572913

Kneifel, Stefan; Cordier, Dominik; Good, Stephan; Ionescu, Mihai C S; Ghaffari, Anthony; Hofer, Silvia; Kretzschmar, Martin; Tolnay, Markus; Apostolidis, Christos; Waser, Beatrice; Arnold, Marlene; Mueller-Brand, Jan; Maecke, Helmut R; Reubi, Jean Claude; Merlo, Adrian (2006). Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance p. Clinical cancer research, 12(12), pp. 3843-50. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-05-2820